Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Rising Pharma Holding, Inc. recalls Duloxetine Delayed-Release Capsules USP 30 mg

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
CGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended interim limit.
Products
  • Duloxetine Delayed-Release Capsules USP 30 mg
Where it was sold

Nationwide

Nationwide

Units affected
42,527 bottles
About this recall
Duloxetine Delayed-Release Capsules USP 30 mg, a) 30 count (NDC 57237-018-30) and b) 1000 count (NDC 57237-018-99) bottles, Rx only, Distributed by: Rising Pharm Holdings, Inc., East Brunswick, NJ